Cholinesterase Inhibitor Therapy in Alzheimer’s Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

(2014) H.-F. Wang et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Treatment effects in multiple cognitive domains in Alzheimer’s disease: a two-year cohort study

(2014) Pearl Behl et al.   Alzheimers Research & Therapy

A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease

(2012) Donald E. Moss et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Functional consequences of repeated organophosphate exposure: Potential non-cholinergic mechanisms

(2012) A.V. Terry   PHARMACOLOGY & THERAPEUTICS

Oxime-assisted Acetylcholinesterase Catalytic Scavengers of Organophosphates That Resist Aging

(2011) Rory Cochran et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease

(2008) Alireza Atri et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Vascular Dementia

(2008) Michael J. Schneck   Topics in Stroke Rehabilitation